Bone Marrow Transplantation (Conference News)

IPOP Care For BMT Patients Less Costly Than Standard Treatment

Published in Cancer Weekly, December 22nd, 1997

Use of a combination in-patient and out-patient continuum of care (IPOP) for bone marrow transplant (BMT) patients resulted in 7 percent lower costs to insurers without significantly shifting costs to patients.

Enhanced outpatient care also appears to be as safe as conventional BMT, J. Rizzo and colleagues from Johns Hopkins University told attendees at the 39th annual meeting of the American Society of Hematology held December 5-9, 1997, in San Diego, California.

BMT traditionally has been performed during lengthy and expensive inpatient hospitalization. The study, conducted at Johns Hopkins Oncology Center in Baltimore, Maryland, provided...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1997-12-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry